Published in Proc Natl Acad Sci U S A on May 01, 1988
Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. Am J Hum Genet (1993) 11.01
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Phenocopies in BRCA1 and BRCA2 families: evidence for modifier genes and implications for screening. J Med Genet (2006) 2.68
Familial breast cancer. BMJ (1994) 2.54
Mutation analysis of BRCA1 and BRCA2 in a male breast cancer population. Am J Hum Genet (1997) 2.53
BayesMendel: an R environment for Mendelian risk prediction. Stat Appl Genet Mol Biol (2004) 2.34
Perception of risk in women with a family history of breast cancer. Br J Cancer (1993) 2.32
Factors affecting statistical power in the detection of genetic association. J Clin Invest (2005) 2.02
BRCA1 maps proximal to D17S579 on chromosome 17q21 by genetic analysis. Am J Hum Genet (1993) 1.90
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
The impact of genetic counselling on risk perception in women with a family history of breast cancer. Br J Cancer (1994) 1.75
Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. Am J Hum Genet (1992) 1.71
An epidemiologic approach to gene-environment interaction. Genet Epidemiol (1990) 1.59
A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families. Am J Hum Genet (1996) 1.45
Genetic epidemiology of early onset breast cancer. J Med Genet (1994) 1.37
After BRCA1 and BRCA2-what next? Multifactorial segregation analyses of three-generation, population-based Australian families affected by female breast cancer. Am J Hum Genet (2000) 1.34
A gene expression signature that defines breast cancer metastases. Clin Exp Metastasis (2008) 1.34
Direct isolation of human BRCA2 gene by transformation-associated recombination in yeast. Proc Natl Acad Sci U S A (1997) 1.30
Oncogenes and human breast cancer. Am J Hum Genet (1989) 1.29
Cancer experience in the relatives of an unselected series of breast cancer patients. Br J Cancer (1994) 1.28
Distal deletion of chromosome Ip in ductal carcinoma of the breast. Am J Hum Genet (1989) 1.25
BRCA1 variants in a family study of African-American and Latina women. Hum Genet (2005) 1.19
Functional assays for BRCA1 and BRCA2. Int J Biochem Cell Biol (2006) 1.15
Breast cancer risk-assessment models. Breast Cancer Res (2007) 1.09
Heritable breast cancer in twins. Br J Cancer (2002) 1.05
Linkage analysis of adult height in a large pedigree from a Dutch genetically isolated population. Hum Genet (2009) 1.04
Screening for 185delAG in the Ashkenazim. Am J Hum Genet (1997) 1.04
Ovarian cancer family and prophylactic choices. J Med Genet (1992) 1.04
Breast cancer in the personal genomics era. Curr Genomics (2010) 1.02
Novel mutations in the BRCA1 and BRCA2 genes in Iranian women with early-onset breast cancer. Breast Cancer Res (2002) 1.02
Linkage analysis of early-onset breast and ovarian cancer families, with markers on the long arm of chromosome 17. Am J Hum Genet (1993) 1.02
Risk assessment and management of high risk familial breast cancer. J Med Genet (2002) 1.01
Hereditary breast cancer: the era of new susceptibility genes. Biomed Res Int (2013) 1.01
BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families. Fam Cancer (2006) 1.00
Hereditary breast cancer in Jews. Fam Cancer (2004) 0.99
Inherited predisposition to breast and ovarian cancer. Am J Hum Genet (1994) 0.98
Risk of cancer in relatives of testicular cancer patients. Br J Cancer (1996) 0.98
Estimating the power of linkage analysis in hereditary breast cancer. Am J Hum Genet (1990) 0.97
Linkage to markers for the chromosome region 17q12-q21 in 13 Dutch breast cancer kindreds. Am J Hum Genet (1993) 0.96
Evaluation of psychosocial effects of pre-symptomatic testing for breast/ovarian and colon cancer pre-disposing genes: a 12-month follow-up. Fam Cancer (2004) 0.95
The effects of interaction between familial and reproductive factors on breast cancer risk: a combined analysis of seven case-control studies. Br J Cancer (1998) 0.94
Perception of screening and risk reduction surgeries in patients tested for a BRCA deleterious mutation. Cancer (2009) 0.93
Whole genomewide linkage screen for neural tube defects reveals regions of interest on chromosomes 7 and 10. J Med Genet (2005) 0.92
Interactions between genetic and reproductive factors in breast cancer risk in a French family sample. Am J Hum Genet (1997) 0.90
Frequent loss of heterozygosity at the DNA mismatch-repair loci hMLH1 and hMSH3 in sporadic breast cancer. Br J Cancer (1999) 0.90
TGFBR1(*)6A and Int7G24A variants of transforming growth factor-beta receptor 1 in Swedish familial and sporadic breast cancer. Br J Cancer (2007) 0.90
Family history, and impact on clinical presentation and prognosis, in a population-based breast cancer cohort from the Stockholm County. Fam Cancer (2006) 0.90
Prevalence of BRCA1 and BRCA2 Germline Mutations in Breast Cancer Women of Multiple Ethnic Region in Northwest China. J Breast Cancer (2013) 0.89
BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients. Fam Cancer (2012) 0.88
Genetic polymorphisms in inflammatory response genes and their associations with breast cancer risk. Croat Med J (2014) 0.85
High occurrence of BRCA1 intragenic rearrangements in hereditary breast and ovarian cancer syndrome in the Czech Republic. BMC Med Genet (2007) 0.84
Human immunodeficiency virus type 1-like DNA sequences and immunoreactive viral particles with unique association with breast cancer. Clin Diagn Lab Immunol (1998) 0.83
Targeted Sequencing of the Mitochondrial Genome of Women at High Risk of Breast Cancer without Detectable Mutations in BRCA1/2. PLoS One (2015) 0.83
Novel family of gynecologic cancer antigens detected by anti-HIV antibody. Infect Dis Obstet Gynecol (1994) 0.82
Novel sequence variants and common recurrent polymorphisms of BRCA2 in Sri Lankan breast cancer patients and a family with BRCA1 mutations. Exp Ther Med (2011) 0.81
Genome-Wide Analysis Identifies Germ-Line Risk Factors Associated with Canine Mammary Tumours. PLoS Genet (2016) 0.81
Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment. Ann Surg Oncol (2008) 0.80
DNA double-strand break repair genotype and phenotype and breast cancer risk within sisters from the New York site of the Breast Cancer Family Registry (BCFR). Cancer Causes Control (2013) 0.80
BRCA1 mutations in a selected series of breast/ovarian cancer patients. J Med Genet (1996) 0.79
Molecular genetics of familial breast-ovarian cancer. J Clin Pathol (1995) 0.79
Frequency of 5382insC mutation of BRCA1 gene among breast cancer patients: an experience from Eastern India. Fam Cancer (2013) 0.79
Fine tuning chemotherapy to match BRCA1 status. Biochem Pharmacol (2010) 0.79
Obesity and Breast Cancer: Molecular Interconnections and Potential Clinical Applications. Oncologist (2016) 0.79
Chromosome 8p alterations in sporadic and BRCA2 999del5 linked breast cancer. J Med Genet (2000) 0.78
Familial risks and estrogen receptor-positive breast cancer in Hong Kong Chinese women. PLoS One (2015) 0.78
Low Frequency Loss of Heterozygosity in the BRCA1 Region in Japanese Sporadic Breast Cancer. Breast Cancer (1996) 0.77
Linkage analysis in German breast cancer families with early onset of the disease, using highly polymorphic markers from the chromosome 17q11-q24 region. Am J Hum Genet (1993) 0.77
Genetic testing for cancer predisposition: need and demand. J Med Genet (1995) 0.77
Is there heterogeneity of age at onset for breast cancer? Am J Hum Genet (1993) 0.77
Genetic anticipation in BRCA1/BRCA2 families after controlling for ascertainment bias and cohort effect. Cancer (2016) 0.76
Exclusion of the retinoblastoma gene and chromosome 13q as the site of a primary lesion for human breast cancer. Am J Hum Genet (1990) 0.75
An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers. Breast Cancer Res (2015) 0.75
Pioneering geneticist Mary-Claire King receives the 2014 Lasker~Koshland Special Achievement Award in Medical Science. J Clin Invest (2014) 0.75
Profile of Mary-Claire King, 2014 Lasker-Koshland Special Achievement in Medical Science awardee. Proc Natl Acad Sci U S A (2014) 0.75
Breast Cancer Genetic Counseling: A Surgeon's Perspective. Front Surg (2016) 0.75
Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A (1971) 31.05
A receptor-mediated pathway for cholesterol homeostasis. Science (1986) 19.28
A polymorphic DNA marker genetically linked to Huntington's disease. Nature (1984) 16.71
Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature (1987) 10.21
A closely linked genetic marker for cystic fibrosis. Nature (1985) 7.85
Localization of cystic fibrosis locus to human chromosome 7cen-q22. Nature (1985) 7.77
Cystic fibrosis locus defined by a genetically linked polymorphic DNA marker. Science (1985) 5.81
A unified model for complex segregation analysis. Am J Hum Genet (1983) 5.67
Chromosome 5 allele loss in human colorectal carcinomas. Nature (1987) 4.46
Gene for hereditary retinoblastoma assigned to human chromosome 13 by linkage to esterase D. Science (1983) 4.43
Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am J Hum Genet (1985) 3.83
Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour. Nature (1984) 3.37
Detecting linkage for genetically heterogeneous diseases and detecting heterogeneity with linkage data. Am J Hum Genet (1986) 3.16
Development of homozygosity for chromosome 11p markers in Wilms' tumour. Nature (1984) 2.97
Somatic deletion and duplication of genes on chromosome 11 in Wilms' tumours. Nature (1984) 2.77
Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature (1987) 2.54
Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst (1985) 2.43
Genetic origin of mutations predisposing to retinoblastoma. Science (1985) 2.22
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst (1983) 2.21
Aniridia-Wilms' tumor association: evidence for specific deletion of 11p13. Cytogenet Cell Genet (1979) 2.18
A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature (1987) 2.15
A genetic epidemiologic investigation of breast cancer in families with bilateral breast cancer. I. Segregation analysis. J Natl Cancer Inst (1987) 1.70
Familial breast cancer in a population-based series. Am J Epidemiol (1986) 1.44
A DNA probe for the LDL receptor gene is tightly linked to hypercholesterolemia in a pedigree with early coronary disease. Am J Hum Genet (1986) 1.32
Cancer incidence and mortality in the United States, 1973-77. Natl Cancer Inst Monogr (1981) 1.31
Epidemiology of breast carcinoma III: relationship of family history to tumor type. Cancer (1982) 1.26
Genetic epidemiology. Annu Rev Public Health (1984) 1.17
Hodgkin's disease susceptibility: linkage to the HLA locus demonstrated by a new concordance method. Hum Immunol (1983) 1.02
Familial breast cancer and the awareness bias. Am J Epidemiol (1987) 0.87
Genetic epidemiology of breast cancer: a comment on heterogeneity. Genet Epidemiol (1985) 0.87
Evolution at two levels in humans and chimpanzees. Science (1975) 21.07
Linkage of early-onset familial breast cancer to chromosome 17q21. Science (1990) 16.21
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Nested retrotransposons in the intergenic regions of the maize genome. Science (1996) 12.95
Comparison of vignettes, standardized patients, and chart abstraction: a prospective validation study of 3 methods for measuring quality. JAMA (2000) 10.91
Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc Chem Res (2000) 10.78
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
Isolation and quantification of soluble Alzheimer's beta-peptide from biological fluids. Nature (1992) 7.02
Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk (1996) 6.18
Identification and characterization of inhibitors of multidrug resistance efflux pumps in Pseudomonas aeruginosa: novel agents for combination therapy. Antimicrob Agents Chemother (2001) 5.23
Comparative genome mapping of Sorghum and maize. Genetics (1992) 5.14
Amyloid precursor protein processing and A beta42 deposition in a transgenic mouse model of Alzheimer disease. Proc Natl Acad Sci U S A (1997) 4.92
Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts. J Infect Dis (1999) 4.67
Case-control study of risk factors for avian influenza A (H5N1) disease, Hong Kong, 1997. J Infect Dis (1999) 4.59
Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain. J Neurochem (2001) 4.45
Single vs weekly courses of antenatal corticosteroids for women at risk of preterm delivery: A randomized controlled trial. JAMA (2001) 4.30
BRCA1 is secreted and exhibits properties of a granin. Nat Genet (1996) 4.26
Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families. Nat Genet (1994) 4.15
Structure of a BRCA1-BARD1 heterodimeric RING-RING complex. Nat Struct Biol (2001) 4.15
Assessing the use of medications in the elderly: methods and initial experience in the Cardiovascular Health Study. The Cardiovascular Health Study Collaborative Research Group. J Clin Epidemiol (1992) 4.11
Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice. Nat Med (1997) 4.10
Appropriateness of the decision to transfer nursing facility residents to the hospital. J Am Geriatr Soc (2000) 3.99
Closing in on a breast cancer gene on chromosome 17q. Am J Hum Genet (1992) 3.89
Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am J Hum Genet (1986) 3.83
Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation (1990) 3.83
How well does chart abstraction measure quality? A prospective comparison of standardized patients with the medical record. Am J Med (2000) 3.70
Growth retardation and tumour inhibition by BRCA1. Nat Genet (1996) 3.47
Population genetics of BRCA1 and BRCA2. Am J Hum Genet (1997) 3.28
Phospholipid:diacylglycerol acyltransferase: an enzyme that catalyzes the acyl-CoA-independent formation of triacylglycerol in yeast and plants. Proc Natl Acad Sci U S A (2000) 3.22
Nonsyndromic deafness DFNA1 associated with mutation of a human homolog of the Drosophila gene diaphanous. Science (1997) 3.21
Detecting linkage for genetically heterogeneous diseases and detecting heterogeneity with linkage data. Am J Hum Genet (1986) 3.16
Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell (1996) 3.01
BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. Hum Mol Genet (2001) 2.98
Haplotype and phenotype analysis of six recurrent BRCA1 mutations in 61 families: results of an international study. Am J Hum Genet (1996) 2.97
Complete genomic sequence and analysis of 117 kb of human DNA containing the gene BRCA1. Genome Res (1996) 2.91
Frequency of breast cancer attributable to BRCA1 in a population-based series of American women. JAMA (1998) 2.76
BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer's disease therapeutics. Hum Mol Genet (2001) 2.76
Methanogenesis in a Thermophilic (58 degrees C) Anaerobic Digestor: Methanothrix sp. as an Important Aceticlastic Methanogen. Appl Environ Microbiol (1984) 2.69
Modern management of spinal tuberculosis. Neurosurgery (1995) 2.55
Absence of association or genetic linkage between the angiotensin-converting-enzyme gene and left ventricular mass. N Engl J Med (1996) 2.49
Are nonspecific practice guidelines potentially harmful? A randomized comparison of the effect of nonspecific versus specific guidelines on physician decision making. Health Serv Res (2000) 2.45
Concordance for type 2 (non-insulin-dependent) diabetes mellitus in male twins. Diabetologia (1987) 2.44
Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst (1985) 2.43
Mutation in transcription factor POU4F3 associated with inherited progressive hearing loss in humans. Science (1998) 2.42
THRA1 and D17S183 flank an interval of < 4 cM for the breast-ovarian cancer gene (BRCA1) on chromosome 17q21. Am J Hum Genet (1993) 2.37
Markers of circulating tumour cells in the peripheral blood of patients with melanoma correlate with disease recurrence and progression. Br J Dermatol (2012) 2.31
High resolution microendoscopy for classification of colorectal polyps. Endoscopy (2013) 2.29
Endostatin inhibits VEGF-induced endothelial cell migration and tumor growth independently of zinc binding. EMBO J (1999) 2.28
Family history as a risk factor for primary cardiac arrest. Circulation (1998) 2.25
Measuring compliance with preventive care guidelines: standardized patients, clinical vignettes, and the medical record. J Gen Intern Med (2000) 2.21
Genetic epidemiology of breast cancer and associated cancers in high-risk families. I. Segregation analysis. J Natl Cancer Inst (1983) 2.21
Three-dimensional visualization of tegument/capsid interactions in the intact human cytomegalovirus. Virology (1999) 2.20
Inferences on the genome structure of progenitor maize through comparative analysis of rice, maize and the domesticated panicoids. Genetics (1999) 2.19
Which clinical anesthesia outcomes are both common and important to avoid? The perspective of a panel of expert anesthesiologists. Anesth Analg (1999) 2.12
Transverse carpal ligament: its effect on flexor tendon excursion, morphologic changes of the carpal canal, and on pinch and grip strengths after open carpal tunnel release. Plast Reconstr Surg (1997) 2.11
Insights into the functions of BRCA1 and BRCA2. Trends Genet (2000) 2.10
Mode of action of pectic enzymes. I. Purification and certain properties of tomato pectinesterase. Biochemistry (1968) 2.07
Psychological effects of ketamine in healthy volunteers. Phenomenological study. Br J Psychiatry (2006) 2.06
Genome-wide association scan for childhood caries implicates novel genes. J Dent Res (2011) 2.05
Construction of an RFLP map in sorghum and comparative mapping in maize. Genome (1994) 1.97
Development and validation of a geriatrics attitudes scale for primary care residents. J Am Geriatr Soc (1998) 1.96
Inherited mutations in PTEN that are associated with breast cancer, cowden disease, and juvenile polyposis. Am J Hum Genet (1997) 1.94
Diet, physical activity, and colorectal cancer among Chinese in North America and China. J Natl Cancer Inst (1990) 1.92
Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci U S A (2001) 1.90
Structure of the Drosophila DNA topoisomerase II gene. Nucleotide sequence and homology among topoisomerases II. J Mol Biol (1989) 1.89
Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet (1994) 1.88
Inherited breast and ovarian cancer. Hum Mol Genet (1995) 1.87
A novel approach to establishing permanent lymphoblastoid cell lines: Epstein-Barr virus transformation of cryopreserved lymphocytes. Am J Hum Genet (1991) 1.86
Teaching social language to moderately handicapped students. J Appl Behav Anal (1986) 1.85
Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. Am J Hum Genet (1995) 1.85
Pulmonary Kaposi's sarcoma in the acquired immune deficiency syndrome. Clinical, radiographic, and pathologic manifestations. Am J Med (1986) 1.85
Mutation analysis of the BRCA1 gene in ovarian cancers. Cancer Res (1995) 1.85
An alpha-particle emitting antibody ([213Bi]J591) for radioimmunotherapy of prostate cancer. Cancer Res (2000) 1.85
Mutations in COL11A2 cause non-syndromic hearing loss (DFNA13). Nat Genet (1999) 1.82
Recombinant interleukin-1 receptor antagonist blocks the proinflammatory activity of endogenous interleukin-1 in rabbit immune colitis. Gastroenterology (1992) 1.79
A selective stain to detect the vagus nerve in the operation of vagotomy. Br J Surg (1969) 1.78
Cell cycle control genes in fission yeast and mammalian cells. Trends Genet (1988) 1.77
Conserved function of mSpry-2, a murine homolog of Drosophila sprouty, which negatively modulates respiratory organogenesis. Curr Biol (1999) 1.75
The effect of response bias on the odds ratio. Am J Epidemiol (1981) 1.73
The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J Biol Chem (1996) 1.72
Linkage of familial breast cancer to chromosome 17q21 may not be restricted to early-onset disease. Am J Hum Genet (1992) 1.71
Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system. Toxicol Appl Pharmacol (1997) 1.71
The growth-related, translationally controlled protein P23 has properties of a tubulin binding protein and associates transiently with microtubules during the cell cycle. J Cell Sci (1999) 1.71
Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden. Am J Hum Genet (1996) 1.69
Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea. J Antimicrob Chemother (2001) 1.68
Direct and indirect costs associated with the onset of seropositive rheumatoid arthritis. Western Consortium of Practicing Rheumatologists. J Rheumatol (2000) 1.67
Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics. Chem Res Toxicol (1993) 1.67
Identifying individuals by sequencing mitochondrial DNA from teeth. Nat Genet (1992) 1.64
Screening for lung cancer using low dose CT scanning. Thorax (2004) 1.64
Pediatricians' attitudes, beliefs, and practices regarding clinical practice guidelines: a national survey. Pediatrics (2000) 1.64
Intestinal Obstruction by Gall-stones. Br Med J (1945) 1.64
Familial and personal medical history of cancer and nervous system conditions among adults with glioma and controls. Am J Epidemiol (1997) 1.63
Cigarette smoking and cancer of bladder and lung. Br Med J (1976) 1.63
Keratocyte loss after corneal deepithelialization in primates and rabbits. Arch Ophthalmol (1994) 1.63
Improvement of thrombocytopenia due to hypersplenism after transjugular intrahepatic portosystemic shunt placement in cirrhotic patients. Am J Gastroenterol (1996) 1.61
Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study. Am J Hum Genet (1998) 1.61
BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2. Am J Hum Genet (1997) 1.60